Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Toni Kim

Pediatric Endocrinology Sandy Springs, GA Medical Doctor

NPI 1518003771 CMS profile 22488

8601 Dunwoody Pl Ste 565, Sandy Springs, GA 30350

Open in the dashboard

General payments

$160,360

341 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$12,598 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Toni Kim of Sandy Springs, GA is reported in the CMS Open Payments database as having received $160,360 across 341 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $12,598 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $40,310 48
2024 General $59,659 80
2023 General $53,503 93
2022 General $4,452 19
2021 General $337 15
2020 General $1,034 40
2019 General $1,066 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Toni Kim
  • Pediatric Endocrinology median
  • Middle half of Pediatric Endocrinology
  • National median

In program year 2025, general payments to Toni Kim were reported at $40,310. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.

Show as a table
Year Toni Kim Pediatric Endocrinology median Middle half National median
2019 $1,066 $196 $68–$845 $163
2020 $1,034 $124 $37–$722 $114
2021 $337 $134 $35–$691 $132
2022 $4,452 $177 $47–$726 $149
2023 $53,503 $236 $75–$887 $160
2024 $59,659 $259 $91–$979 $164
2025 $40,310 $293 $106–$1,640 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ascendis Pharma, Inc. $140,492 208 payments
  2. Neurocrine Biosciences, Inc. $10,976 16 payments
  3. Pfizer Inc. $5,937 11 payments
  4. Novo Nordisk Inc $550 20 payments
  5. Tolmar, Inc. $425 4 payments
  6. Insulet Corporation $356 18 payments
  7. AbbVie, Inc. $342 13 payments
  8. Abbott Laboratories $303 4 payments
  9. Xeris Pharmaceuticals, Inc. $171 10 payments
  10. Alexion Pharmaceuticals, Inc. $104 5 payments
  11. Other $704 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $107,723 37 payments
  2. Travel and Lodging $30,113 96 payments
  3. Consulting Fee $15,114 4 payments
  4. Food and Beverage $6,615 191 payments
  5. Honoraria $400 1 payment
  6. Education $396 12 payments
Products named General payments · program years 2019–2025
  1. SKYTROFA $128,608 190 payments
  2. CRENESSITY $9,976 15 payments
  3. NGENLA $5,006 2 payments
  4. GENOTROPIN $931 9 payments
  5. FENSOLVI $448 5 payments
  6. Omnipod $356 18 payments
  7. FreeStyle Libre Pro $250 1 payment
  8. Norditropin $190 9 payments
  9. GVOKE PFS $171 10 payments
  10. LUPRON DEPOT $168 8 payments
  11. Other $1,315 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

341 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Endocrinology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record